Screener
Theravance Biopharma TBPH Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Theravance Biopharma’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 8:00 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-093773
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | (5,898) | 54,835 | $(10,831) | $41,256 |
| Net unrealized loss on available-for-sale investments | (14) | (10) | (137) | (17) |
| Total comprehensive income (loss) | $(5,912) | $54,825 | $(10,968) | $41,239 |
| Net income (loss) per share: | ||||
| Net income (loss) per share - basic | $(0.11) | $1.09 | $(0.21) | $0.83 |
| Net income (loss) per share - diluted | $(0.11) | $1.08 | $(0.21) | $0.81 |
| Shares used to compute net income (loss) per share - basic | 51,667 | 50,177 | 51,474 | 49,943 |
| Shares used to compute net income (loss) per share - diluted | 51,667 | 50,726 | 51,474 | 50,685 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Theravance Biopharma's shares (diluted)?
- Theravance Biopharma (TBPH) reported shares (diluted) of 51.7M in Q2 2026.
- How has Theravance Biopharma's shares (diluted) changed year-over-year?
- Theravance Biopharma's shares (diluted) increased by 1.9% year-over-year, from 50.7M to 51.7M.
- What is the long-term trend for Theravance Biopharma's shares (diluted)?
- Over 4 years (2021 to 2025), Theravance Biopharma's shares (diluted) has grown at a -7.1% compound annual growth rate (CAGR), from 273.2M to 203.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Theravance Biopharma's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude